Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

Banks & NBFCs 4QFY21 Results Preview - HDFC Securities

Posted On: 2021-04-14 00:59:23 (Time Zone: Arizona, USA)

Mr. Krishnan ASV, Institutional Research Analyst, HDFC Securities

Beyond a favourable base

We expect our coverage universe to clock a sequential PPOP growth of ~10% on the back of improving business traction. With the SC-imposed standstill on NPL recognition lifted, lenders should report a significant rise in slippages and GNPAs. We expect incremental provisions to moderate sequentially across our coverage universe, with lenders having built significant provision buffers during 9MFY21. We expect sequential improvement in business traction in line with rising economic activity.

Our FY22/23E estimates for our coverage remain relatively unchanged, despite the rapidly strengthening second wave of COVID-19 cases in India. This reflects our belief that our current estimates around credit growth and asset quality already factor in potential speed bumps on the path to recovery. Further, sustained fiscal and monetary policy support and the unexpectedly sharp (at the time) recovery in economic activity over 9MFY21 suggest that the potential fallout of slowing real economic activity on the financial system is unlikely to be material.

Our core thesis remains relatively unchanged, and we continue to favour large banks. ICICIBC remains our top pick with a target price of INR645; our thesis is anchored on a strong balance sheet (strong deposit franchise and adequate provision buffer), comfortable capitalisation and consequent ability to disproportionately gain market share. SBIN, too, offers an attractive risk-reward (target price INR462), especially with rising confidence on asset quality performance. Amongst the mid-sized banks, we prefer CUBK (target price INR198) and FB (target price of INR98). From amongst our NBFC coverage universe, we prefer CIFC (target price INR622) and CREDAG (target price INR819). We build in a multiple re-rating in CIFC (4.0x Mar'23 ABVPS) reflecting potential tailwinds likely to accrue to the strongest NBFCs. We downgrade MMFS to ADD reflecting the moderate earnings downgrades to factor in the potential vulnerabilities in its asset book.

All eyes on asset quality: With the SC standstill on NPL recognition lifted, lenders are likely to report a significant rise in slippages and NPLs. However, this should not come as a surprise as most lenders indicated potential stress in the form of pro forma GNPAs in earlier quarters. Asset quality will continue to be the primary area of concern for investors as strengthening recovery in real economic activity in 4Q is met by localised lockdowns amidst rising COVID-19 infections. We will watch for lenders' commentary on recent collection efficiency trends and early-bucket delinquencies. We continue to factor in a gradual improvement in asset quality in FY22E across most of our coverage universe, and we believe that our existing estimates adequately factor in potential speed bumps along the way.

Provisions to dip: Even as reported stress is set to rise, we expect most of our coverage companies (both banks and NBFCs) to register a sequential decline (-18.9% (ex-SBI) across our coverage universe) in non-tax provisions. Consequently, reported PCR may fall optically. For some of the larger banks, recovery from a large NCLT account could be an offset factor. We will watch out for commentary on the need for potential further provisions/ utilisation of current provisions, considering the resurgence in COVID-19 infections.

Sequential uptick in credit growth: Lenders within our coverage universe can see a sequential improvement in credit growth to 3.5%, in line with rising levels of real economic activity seen throughout most of 4Q and the previous quarter's guidance by most lenders. RBI data suggests that system-level credit grew 6.5% YoY until 12th March 2021 and 2.4% between 18th December 2020 and 12th March 2021. Sector-wise bank credit trends indicated robust growth in agricultural credit and improving trends in growth in credit for services and personal loans even as industrial credit continued to languish. Most asset and home financiers within our coverage universe are likely to have seen disbursal momentum sustain/ improve into 4Q. Large well-sponsored NBFCs such as CIFC are likely to fare well on this front, as funding-side benefits allow them to capture resurgent growth.

Strong deposit accretion to continue: Until 12 March 2021, system-level deposits grew 12.1% YoY and 3.3% between December 18th and 12th March, ahead of systemic credit growth. We expect similar trends across most of our coverage universe, which is corroborated by provisional updates released by select banks.

Margins could improve: Banks within our coverage are likely to exhibit stable-to-increasing margins. An analysis of system-level data indicates that weighted average lending rates on private banks' outstanding loans declined by less than 10bps between December and February, even as private banks' median MCLR dipped ~70bps over the past 12 months. Further, the downtrend in private banks' weighted average term deposit rates has continued (~10bps between December and February 2021). Lower liquidity buffers and strong CASA accretion will be further tailwinds to margins. While interest reversals on slippages pose a risk to margins, several banks have already made adequate income reversals/ provisions on pro forma slippages. NBFCs within our coverage will continue to benefit from a benign interest rate environment even as they witness asset-side re-pricing.

Operating expenditure to normalise: With rising levels of economic activity and increasing business volumes, most lenders within our coverage universe should see operating costs inch up to pre-COVID-19 levels. Consequently, efficiency ratios will deteriorate sequentially. This will also allow investors to identify and evaluate the impact of structural cost reduction measures made by lenders over the past year.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Dabur India: REDUCE - Q4FY21 Result Update - YES Securities

Maintain BUY on CreditAccess Grameen - Accelerated write-offs dents earnings - HDFC Securities

Sundram Fasteners Q4 Results Review - HDFC Securities

SRF - Specialty Chemicals continues to shine! - HDFC Securities

Realtors welcome RBI latest stance, expect relief initiatives in next announcement

CreditAccess Grameen - Q4FY21 Result Update - ICICI Securities

JM Financial - Exits FY21 with well contained stress pool; sequential AUM uptick encouraging - ICICI Securities

Hero MotoCorp - Margins remain resilient - ICICI Securities

CEAT - Margin pressures likely to intensify - ICICI Securities

SRF Limited - FY22E growth capped on higher plants utilisation - ICICI Securities

I-direct Instinct - Automotive Axles - ICICI Direct

Quant Pick - Axis Bank - ICICI Direct

Gladiator Stocks - Caplin Point Laboratories - ICICI Direct

Q4FY21 Result Update - Coforge Ltd - ICICI Direct

Tata Consumer Products - Q4FY21 First Cut - ICICI Direct

Coforge Ltd - Q4FY21 Result Update - YES Securities

CreditAccess Grameen - Q4FY21 Result Update - YES Securities

Blue Star - Q4 FY21 first cut - Inline performance - YES Securities

Tata Consumer - 4QFY21 results first cut - YES Securities

Tata Consumer 4QFY21 results first cut - YES Securities

Maintain BUY on CDSL - Strong growth momentum - HDFC Securities

Maintain ADD on L&T Infotech - Steady progression - HDFC Securities

Blue Dart Express - Q4FY21 - The bulge continues - ICICI Securities

Tata Steel - FY22E Net Debt/EBITDA at <1x - ICICI Securities

Larsen & Toubro Infotech - Consistency continues! - ICICI Securities

CEAT - Decent quarter; new capex likely to curtail FCF - ICICI Securities

Q4FY21 Result Update - Alembic Pharma - ICICI Direct

Gladiator Stocks - Cadila Healthcare - ICICI Direct

Q4FY21 Result Update - Larsen & Toubro Infotech - ICICI Direct

RBI Action Update - May 2021 - ICICI Direct

Quant Pick - Aurobindo Pharma - ICICI Direct

Q4FY21 Result Update - Greaves Cotton - ICICI Direct

Adani Total Gas Ltd - Q4FY21 Result Update - YES Securities

L&T Infotech - Q4FY21 Result Update - YES Securities

Bluedart Express - Q4 FY21 first cut - Miss on topline; Profitability improves - YES Securities

Views on the announcement by RBI Governor - Ms. Bekxy Kuriakose, Head - Fixed Income, Principal Asset Management

Views from experts on RBI announcement - May 5, 2021

Maintain REDUCE on RBL Bank - Elevated retail slippages continue - HDFC Securities

Resolution 2.0 measure by RBI to provide relief to real estate linked SME stakeholders

Godrej Properties - Robust quarter; positives fairly priced in - HDFC Securities

RBI Relief 2.0 - May 2021 - Acuité Ratings & Research

MDF Industry - Countervailing duty on MDF recommended; imports may get hit structurally - ICICI Securities

Home First Finance Company - Core earnings steady; profitability buoyed by securitisation income - ICICI Securities

RBL Bank - Modest return profile in the interim; transitioning underway - ICICI Securities

Alembic Pharmaceuticals - US continues to be under pressure - ICICI Securities

Q4FY21 Result Update - SBI Life Insurance - ICICI Direct

Q1CY21 Result Update - Varun Beverages - ICICI Direct

RBL Bank: Views from leading research houses on Q4FY21 results

Q4FY21 Result Update - Supreme Industries - ICICI Direct

Q4FY21 Result Update - Tata Chemicals - ICICI Direct

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020